EP08.02-140 MET Biomarker-based Preliminary Efficacy Analysis in SAVANNAH: savolitinib+osimertinib in EGFRm NSCLC Post-Osimertinib
M-j. Ahn, F. De Marinis, L. Bonanno, B.C. Cho, Tae‐Min Kim, S. Cheng, S. Novello, C. Proto, S.-W. Kim, J.S. Lee, G. Metro, J.C. Yang, W. Xu, Ryan J. Hartmaier, A. Telaranta-Keerie, L. Poole, Lecia V. Sequist
Topics & Concepts
OsimertinibMedicineOncologyBiomarkerInternal medicineEpidermal growth factor receptorCancerChemistryBiochemistryErlotinibLung Cancer Treatments and MutationsColorectal Cancer Treatments and StudiesGastric Cancer Management and Outcomes